Pathological complete response following cisplatin or carboplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: A systematic review and meta-analysis.

Vidra, Radu; Nemes, Adina; Vidrean, Andreea; Pintea, Sebastian; Tintari, Snejeana; Deac, Andrada; Ciuleanu, Tudor

Vidra, Radu; Nemes, Adina; Vidrean, Andreea; Pintea, Sebastian; Tintari, Snejeana; Deac, Andrada; Ciuleanu, Tudor.

Afiliación

Vidra R; Department of Oncology, 'Iuliu Hatieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
Nemes A; Department of Oncology, 'Prof. Dr. Ion Chiricuta' Oncology Institute, 400015 Cluj-Napoca, Romania.
Vidrean A; Department of Oncology, 'Prof. Dr. Octavian Fodor' Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania.
Pintea S; Department of Oncology, 'Iuliu Hatieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
Tintari S; Department of Oncology, 'Prof. Dr. Ion Chiricuta' Oncology Institute, 400015 Cluj-Napoca, Romania.
Deac A; Department of Oncology, 'Prof. Dr. Ion Chiricuta' Oncology Institute, 400015 Cluj-Napoca, Romania.
Ciuleanu T; Department of Psychology, 'BabeÈ-Bolyai' University, 400084 Cluj-Napoca, Romania.

Exp Ther Med ; 23(1): 91, 2022 Jan.

Article en En | MEDLINE | ID: mdl-34934456

Palabras clave

BRCA mutation; carboplatin; cisplatin; pathological complete response; platinum-based neoadjuvant chemotherapy; triple-negative breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Systematic_reviews Idioma: En Revista: Exp Ther Med Año: 2022 Tipo del documento: Article País de afiliación: Rumanía

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google